(Q46562134)

English

Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a.

scientific article published in June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

glycogen storage disease

1 reference

based on heuristic

inferred from title

author name string

Robert H J Bandsma

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

Berthil H Prinsen

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

Monique de Sain van Der Velden

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

Jan-Peter Rake

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

Theo Boer

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

G Peter A Smit

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

Dirk-Jan Reijngoud

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

Folkert Kuipers

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

language of work or name

0 references

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

Pediatric Research

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

63

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

702-707

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

https://scigraph.springernature.com/pub.10.1203/pdr.0b013e31816c9013

0 references

Type I glycogen storage disease: nine years of management with cornstarch

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a.

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Coordinate regulation of lipogenesis, the assembly and secretion of apolipoprotein B-containing lipoproteins by sterol response element binding protein 1.

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Triglyceride Clearing in Glycogen Storage Disease

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Very low-density lipoprotein apolipoprotein B-100 turnover in glycogen storage disease type Ia (von Gierke disease).

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans.

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Glucose regulation of the acetyl-CoA carboxylase promoter PI in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Regulation of the expression of lipogenic enzyme genes by carbohydrate

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2.

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Overproduction of large VLDL particles is driven by increased liver fat content in man.

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Glycogen storage disease, types I to X: criteria for morphologic diagnosis

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Glycerol clearance in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: Measurements with stable isotopes

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

In VivoDetermination of Very-Low-Density Lipoprotein–Apolipoprotein B100 Secretion Rates in Humans with a Low Dose ofl-[1-13C]Valine and Isotope Ratio Mass Spectrometry

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E31816C9013

21 January 2018

Identifiers

10.1203/PDR.0B013E31816C9013

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18520334

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46562134&oldid=2099089884"